Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bemiparin for Prevention of Recurrent Stillbirth
NCT03601338Phase 1Completed
- Sponsor
- Hawler Medical University
- Start
- Aug 2015
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of bemiparin in stillbirth (2 arms), sponsored by Hawler Medical University. Primary endpoints: Stillbirth, Early neonatal death and 1 more. Started Aug 2015; status: completed.
02
Drugs
bemiparin
03
Conditions
stillbirth
Beyond the preview
Go deeper on NCT03601338.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03601338.